PTK2 and non-small cell lung carcinoma: To further verify the critical role of EZH2 in FAK-mediated anti-senescence signaling, we explored whether EZH2 overexpression bypasses FAK-inhibition-induced cellular senescence in non-small cell lung cancer cells.